Said Chosro Farschtschi
Publications
- 2024
Treatment of Cerebral Histiocytosis With Low Dose of Cobimetinib: A Report of 2 Cases
Schubert, C., Schiffmann, I., Farschtschi, S. C., Emile, J-F. & Friese, M. A., 05.2024, In: NEUROL-NEUROIMMUNOL. 11, 3, p. e200233Research output: SCORING: Contribution to journal › Case report › Research › peer-review
Asymmetry of thalamic hypometabolism on FDG-PET/CT in neurofibromatosis type 1: Association with peripheral tumor burden
Özden, C., Mautner, V-F., Farschtschi, S., Molwitz, I., Ristow, I., Bannas, P., Well, L., Klutmann, S., Adam, G., Apostolova, I. & Buchert, R., 2024, In: J NEUROIMAGING. 34, 1, p. 138-144 7 p.Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
- 2023
Atypical Neurofibromas reveal distinct epigenetic features with proximity to benign peripheral nerve sheath tumor entities
Kresbach, C., Dottermusch, M., Eckhardt, A., Ristow, I., Paplomatas, P., Altendorf, L., Wefers, A. K., Bockmayr, M., Belakhoua, S., Tran, I., Pohl, L., Neyazi, S., Bode, H., Farschtschi, S., Well, L., Friedrich, R. E., Reuss, D., Snuderl, M., Hagel, C., Mautner, V-F. & Schüller, U., 05.09.2023, In: NEURO-ONCOLOGY. 25, 9, p. 1644-1655 12 p.Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
ERN GENTURIS tumour surveillance guidelines for individuals with neurofibromatosis type 1
Carton, C., Evans, D. G., Blanco, I., Friedrich, R. E., Ferner, R. E., Farschtschi, S., Salvador, H., Azizi, A. A., Mautner, V., Röhl, C., Peltonen, S., Stivaros, S., Legius, E., Oostenbrink, R. & ERN GENTURIS NF1 Tumour Management Guideline Group, 02.2023, In: ECLINICALMEDICINE. 56, 101818.Research output: SCORING: Contribution to journal › SCORING: Review article › Research
Medical Cannabis Alleviates Chronic Neuropathic Pain Effectively and Sustainably without Severe Adverse Effect: A Retrospective Study on 99 Cases
Kluwe, L., Scholze, C., Schmidberg, L. M., Wichmann, J. L., Gemkov, M., Keller, M. J. & Farschtschi, S. C., 2023, In: Medical cannabis and cannabinoids. 6, 1, p. 89-96 8 p.Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
- 2022
Evaluation of magnetic resonance imaging-based radiomics characteristics for differentiation of benign and malignant peripheral nerve sheath tumors in neurofibromatosis type 1
Ristow, I., Madesta, F., Well, L., Shenas, F. Y., Wright, F., Molwitz, I., Farschtschi, S., Bannas, P., Adam, G., Mautner, V. F., Werner, R. & Salamon, J., 03.10.2022, In: NEURO-ONCOLOGY. 24, 10, p. 1790-1798 9 p.Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
Spatial Distribution and Long-Term Alterations of Peripheral Nerve Lesions in Schwannomatosis
Godel, T., Bäumer, P., Farschtschi, S., Hofstadler, B., Heiland, S., Gelderblom, M., Bendszus, M. & Mautner, V-F., 23.03.2022, In: DIAGNOSTICS. 12, 4, 780.Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
Long-term Follow-up and Histological Correlation of Peripheral Nervous System Alterations in Neurofibromatosis Type 2
Godel, T., Bäumer, P., Farschtschi, S., Püschel, K., Hofstadler, B., Heiland, S., Gelderblom, M., Bendszus, M., Hagel, C. & Mautner, V-F., 03.2022, In: CLIN NEURORADIOL. 32, 1, p. 277-285 9 p.Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
- 2021
Revidierte Diagnosekriterien für die Neurofibromatose Typ 1 (NF1) ermöglichen eine frühe präzise differenzialdiagnostische Abgrenzung zu anderen RASopathien und erleichtern die Diagnose
Kehrer-Sawatzki, H., Farschtschi, S. C. & Mautner, V-F., 30.09.2021, In: MONATSSCHR KINDERH.Research output: SCORING: Contribution to journal › SCORING: Review article › Research
Author Correction: Phenotyping spinal abnormalities in patients with Neurofibromatosis type 1 using whole-body MRI
Well, L., Careddu, A., Stark, M., Farschtschi, S., Bannas, P., Adam, G., Mautner, V-F. & Salamon, J., 30.08.2021, In: SCI REP-UK. 11, 1, p. 17669Research output: SCORING: Contribution to journal › Other (editorial matter etc.) › Research
Genotype-phenotype correlation in neurofibromatosis type-1: NF1 whole gene deletions lead to high tumor-burden and increased tumor-growth
Well, L., Döbel, K., Kluwe, L., Bannas, P., Farschtschi, S., Adam, G., Mautner, V-F. & Salamon, J., 05.2021, In: PLOS GENET. 17, 5, p. e1009517Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
In Reply Letter to the Editor The Neurofibromatoses by Dr. med. Said Farschtschi, Prof. Dr. med. Victor-Felix Mautner, Dr. med. Anna Cecilia Lawson McLean, Dr. med. Dr. rer. nat. Alexander Schulz, Prof. Dr. med. Dr. med. dent. Reinhard E. Friedrich, Prof. Dr. med. Steffen K. Rosahl in issue 20/2020
Farschtschi, S., 29.01.2021, In: DTSCH ARZTEBL INT. 118, 4, p. 56Research output: SCORING: Contribution to journal › Other (editorial matter etc.) › Research
- 2020
Clinical characterization of children and adolescents with NF1 microdeletions
Kehrer-Sawatzki, H., Kluwe, L., Salamon, J., Well, L., Farschtschi, S., Rosenbaum, T. & Mautner, V-F., 10.2020, In: CHILD NERV SYST. 36, 10, p. 2297-2310 14 p.Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
MRI based volumetric measurements of vestibular schwannomas in patients with neurofibromatosis type 2: comparison of three different software tools
Kollmann, P., Mautner, V-F., Koeppen, J., Wenzel, R., Friedman, J. M., Salamon, J. & Farschtschi, S., 14.07.2020, In: SCI REP-UK. 10, 1, p. 11541Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
Null phenotype of neurofibromatosis type 1 in a carrier of a heterozygous atypical NF1 deletion due to mosaicism
Kluwe, L., Friedrich, R. E., Farschtschi, S. C., Hagel, C., Kehrer-Sawatzki, H. & Mautner, V-F., 07.2020, In: HUM MUTAT. 41, 7, p. 1226-1231 6 p.Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
Upregulated immuno-modulator PD-L1 in malignant peripheral nerve sheath tumors provides a potential biomarker and a therapeutic target
Farschtschi, S., Kluwe, L., Park, S-J., Oh, S-J., Mah, N., Mautner, V-F. & Kurtz, A., 07.2020, In: CANCER IMMUNOL IMMUN. 69, 7, p. 1307-1313 7 p.Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
C-Fiber Loss as a Possible Cause of Neuropathic Pain in Schwannomatosis
Farschtschi, S. C., Mainka, T., Glatzel, M., Hannekum, A-L., Hauck, M., Gelderblom, M., Hagel, C., Friedrich, R. E., Schuhmann, M. U., Schulz, A., Morrison, H., Kehrer-Sawatzki, H., Luhmann, J., Gerloff, C., Bendszus, M., Bäumer, P. & Mautner, V-F., 18.05.2020, In: INT J MOL SCI. 21, 10Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
The Neurofibromatoses
Farschtschi, S., Mautner, V-F., McLean, A. C. L., Schulz, A., Friedrich, R. & Rosahl, S. K., 15.05.2020, In: DTSCH ARZTEBL INT. 117, 20, p. 354-360 7 p.Research output: SCORING: Contribution to journal › SCORING: Review article › Research
Distinctive low epidermal nerve fiber density in schwannomatosis patients provides a major parameter for diagnosis and differential diagnosis
Farschtschi, S. C., Kluwe, L., Schön, G., Friedrich, R. E., Matschke, J., Glatzel, M., Hagel, C. & Mautner, V-F., 03.2020, In: BRAIN PATHOL. 30, 2, p. 386-391 6 p.Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
The effect of pregnancy on growth-dynamics of neurofibromas in Neurofibromatosis type 1
Well, L., Jaeger, A., Kehrer-Sawatzki, H., Farschtschi, S., Avanesov, M., Sauer, M., de Sousa, M. T., Bannas, P., Derlin, T., Adam, G., Mautner, V. F. & Salamon, J. M., 2020, In: PLOS ONE. 15, 4, p. e0232031Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
- 2019
Early-onset stroke in two siblings with Neurofibromatosis type 1
Rukavina, K., Töpper, R., Kunze, A., Hess, A., Glatzel, M., Valdueza, J. M., Farschtschi, S. & Hagel, C., 10.2019, In: EUR J MED GENET. 62, 10, p. 103710Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
Peripheral nervous system alterations in infant and adult neurofibromatosis type 2
Godel, T., Bäumer, P., Farschtschi, S., Gugel, I., Kronlage, M., Hofstadler, B., Heiland, S., Gelderblom, M., Bendszus, M. & Mautner, V-F., 06.08.2019, In: NEUROLOGY. 93, 6, p. e590-e598Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
Differentiation of peripheral nerve sheath tumors in patients with neurofibromatosis type 1 using diffusion-weighted magnetic resonance imaging
Well, L., Salamon, J. M., Kaul, M. G., Farschtschi, S., Herrmann, J., Geier, K. I., Hagel, C., Bockhorn, M., Bannas, P., Adam, G., Mautner, V. F. & Derlin, T., 18.03.2019, In: NEURO-ONCOLOGY. 21, 4, p. 508-516 9 p.Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
- 2018
Phenotypic and genotypic overlap between mosaic NF2 and schwannomatosis in patients with multiple non-intradermal schwannomas
Kehrer-Sawatzki, H., Kluwe, L., Friedrich, R. E., Summerer, A., Schäfer, E., Wahlländer, U., Matthies, C., Gugel, I., Farschtschi, S., Hagel, C., Cooper, D. N. & Mautner, V-F., 07.2018, In: HUM GENET. 137, 6-7, p. 543-552 10 p.Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
Serial MRIs provide novel insight into natural history of optic pathway gliomas in patients with neurofibromatosis 1
Sellmer, L., Farschtschi, S., Marangoni, M., Heran, M. K. S., Birch, P., Wenzel, R., Mautner, V-F. & Friedman, J. M., 23.04.2018, In: ORPHANET J RARE DIS. 13, p. 62Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
Dorsal root ganglia volume differentiates schwannomatosis and neurofibromatosis 2
Godel, T., Mautner, V-F., Farschtschi, S., Pham, M., Schwarz, D., Kronlage, M., Gugel, I., Heiland, S., Bendszus, M. & Bäumer, P., 04.2018, In: ANN NEUROL. 83, 4, p. 854-857 4 p.Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
Neuropathies in the setting of Neurofibromatosis tumor syndromes: Complexities and opportunities
Schulz, A., Grafe, P., Hagel, C., Bäumer, P., Morrison, H., Mautner, V-F. & Farschtschi, S., 01.01.2018, In: EXP NEUROL. 299, Pt B, p. 334-344 11 p.Research output: SCORING: Contribution to journal › SCORING: Review article › Research
- 2017
Muscle action potential scans and ultrasound imaging in neurofibromatosis type 2
Farschtschi, S., Gelderblom, M., Buschbaum, S., Bostock, H., Grafe, P. & Mautner, V. F., 03.2017, In: MUSCLE NERVE. 55, 3, p. 350-358Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
Non-optic glioma in adults and children with neurofibromatosis 1
Sellmer, L., Farschtschi, S., Marangoni, M., Heran, M. K. S., Birch, P., Wenzel, R., Friedman, J. M. & Mautner, V-F., 15.02.2017, In: ORPHANET J RARE DIS. 12, 1, p. 34Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
The molecular pathogenesis of schwannomatosis, a paradigm for the co-involvement of multiple tumour suppressor genes in tumorigenesis
Kehrer-Sawatzki, H., Farschtschi, S., Mautner, V-F. & Cooper, D. N., 02.2017, In: HUM GENET. 136, 2, p. 129-148Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
Therapie und Verlauf neurologischer Erkrankungen: Kapitel H7: Neurokutane Syndrome
Farschtschi, S. C., Tatagiba, M. & Mautner, V-F., 2017, Therapie und Verlauf neurologischer Erkrankungen. Diener, H-C., Gerloff, C. & Dieterich, M. (eds.). 7 ed. Stuttgart: Kohlhammer, p. 997 - 1006 10 p.Research output: SCORING: Contribution to book/anthology › SCORING: Contribution to collected editions/anthologies › Education › peer-review
- 2016
Muskelaktionspotenzial-Scan und Ultraschall zur Erfassung der Neuropathie bei der Neurofibromatose Typ 2
Farschtschi, S. C., Gelderblom, M., Buschbaum, S., Bostock, H., Grafe, P. & Mautner, V-F., 19.11.2016, 20. Tagung der Arbeitsgemeinschaft Neurofibromatose.Research output: SCORING: Contribution to book/anthology › Conference contribution - Poster › Research
Multifocal Nerve Lesions and LZTR1 Germline Mutations in Segmental Schwannomatosis
Farschtschi, S., Mautner, V-F., Pham, M., Nguyen, R., Kehrer-Sawatzki, H., Hutter, S., Friedrich, R. E., Schulz, A., Morrison, H., Jones, D. T. W., Bendszus, M. & Bäumer, P., 10.2016, In: ANN NEUROL. 80, 4, p. 625-8Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
Effector T cell subclasses associate with tumor burden in neurofibromatosis type 1 patients
Farschtschi, S., Park, S-J., Sawitzki, B., Oh, S-J., Kluwe, L., Mautner, V. F. & Kurtz, A., 09.2016, In: CANCER IMMUNOL IMMUN. 65, 9, p. 1113-1121Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
Current whole-body MRI applications in the neurofibromatoses: NF1, NF2, and schwannomatosis
Ahlawat, S., Fayad, L. M., Khan, M. S., Bredella, M. A., Harris, G. J., Evans, D. G., Farschtschi, S., Jacobs, M. A., Chhabra, A., Salamon, J. M., Wenzel, R., Mautner, V. F., Dombi, E., Cai, W., Plotkin, S. R., Blakeley, J. O. & Whole Body MRI Committee for the REiNS International Collaboration, 16.08.2016, In: NEUROLOGY. 87, 7 Suppl 1, p. S31-9Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
Bevacizumab treatment for symptomatic spinal ependymomas in neurofibromatosis type 2
Farschtschi, S., Merker, V. L., Wolf, D., Schuhmann, M., Blakeley, J., Plotkin, S. R., Hagel, C. & Mautner, V. F., 06.2016, In: ACTA NEUROL SCAND. 133, 6, p. 475-480Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
Schwannomatose
Mautner, V-F. & Farschtschi, S. C., 2016, Ratgeber Schwannomatose: Schwannomatose. 1 ed. Hamburg: Bundesverband Neurofibromatose e.V., 27 p.Research output: SCORING: Contribution to book/anthology › SCORING: Contribution to collected editions/anthologies › Education
- 2015
Reduced dosage of bevacizumab in treatment of vestibular schwannomas in patients with neurofibromatosis type 2
Farschtschi, S., Kollmann, P., Dalchow, C., Stein, A. & Mautner, V-F., 12.2015, In: EUR ARCH OTO-RHINO-L. 272, 12, p. 3857-60 4 p.Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
Quantitative associations of scalp and body subcutaneous neurofibromas with internal plexiform tumors in neurofibromatosis 1
Jett, K., Nguyen, R., Arman, D., Birch, P., Chohan, H., Farschtschi, S., Fuensterer, C., Kluwe, L., Friedman, J. M. & Mautner, V. F., 07.2015, In: AM J MED GENET A. 167, 7, p. 1518-24 7 p.Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
Growth in neurofibromatosis 1 microdeletion patients
Ning, X., Farschtschi, S., Jones, A., Kehrer-Sawatzki, H., Mautner, V-F. & Friedman, J. M., 26.06.2015, In: CLIN GENET. 89, 3, p. 351-354Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
Keratinocytic epidermal nevus syndrome with Schwann cell proliferation, lipomatous tumour and mosaic KRAS mutation
Farschtschi, S., Mautner, V-F., Hollants, S., Hagel, C., Spaepen, M., Schulte, C., Legius, E. & Brems, H., 01.01.2015, In: BMC MED GENET. 16, 1, p. 6Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
Critical Role of Platelet Glycoprotein Ibα in Arterial Remodeling
Chandraratne, S., von Bruehl, M-L., Pagel, J-I., Stark, K., Kleinert, E., Konrad, I., Farschtschi, S., Coletti, R., Gärtner, F., Chillo, O., Legate, K. R., Lorenz, M., Rutkowski, S., Caballero-Martinez, A., Starke, R., Tirniceriu, A., Pauleikhoff, L., Fischer, S., Assmann, G., Mueller-Hoecker, J., Ware, J., Nieswandt, B., Schaper, W., Schulz, C., Deindl, E. & Massberg, S., 2015, In: ARTERIOSCL THROM VAS. 35, 3, p. 589-597Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
Faszikuläre Mikroläsionen und Neuropathie bei der Schwannomatose
Farschtschi, S. C., Bäumer, P., Anna-Lena, H., Hauck, M., Gelderblom, M., Peter, G., Pham, M. & Mautner, V-F., 2015, 88. Kongress der Deutschen Gesellschaft für Neurologie mit Fortbildungsakademie.Research output: SCORING: Contribution to book/anthology › Conference contribution - Poster › Research
Multiple Parameter der Nervenerregbarkeit bei der NF2
Peter, G., Farschtschi, S. C., Bostock, H. & Mautner, V-F., 2015, 88. Kongress der Deutschen Gesellschaft für Neurologie mit Fortbildungsakademie.Research output: SCORING: Contribution to book/anthology › Conference contribution - Poster › Research
Recent developments in neurofibromatoses and RASopathies: Management, diagnosis and current and future therapeutic avenues
Rauen, K. A., Huson, S. M., Burkitt-Wright, E., Evans, D. G., Farschtschi, S., Ferner, R. E., Gutmann, D. H., Hanemann, C. O., Kerr, B., Legius, E., Parada, L. F., Patton, M., Peltonen, J., Ratner, N., Riccardi, V. M., van der Vaart, T., Vikkula, M., Viskochil, D. H., Zenker, M. & Upadhyaya, M., 2015, In: AM J MED GENET A. 167A, 1, p. 1-10Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
- 2014
Whole exome sequencing reveals that the majority of schwannomatosis cases remain unexplained after excluding SMARCB1 and LZTR1 germline variants
Hutter, S., Piro, R. M., Reuss, D. E., Hovestadt, V., Sahm, F., Farschtschi, S., Kehrer-Sawatzki, H., Wolf, S., Lichter, P., von Deimling, A., Schuhmann, M. U., Pfister, S. M., Jones, D. T. W. & Mautner, V. F., 01.09.2014, In: ACTA NEUROPATHOL. 128, 3, p. 449-52 4 p.Research output: SCORING: Contribution to journal › Other (editorial matter etc.) › Research
Neuropathischer Schmerz ohne Neuropathie bei der Schwannomatose
Farschtschi, S. C., Bäumer, P., Anna-Lena, H., Hauck, M., Gelderblom, M., Peter, G. & Mautner, V-F., 2014, 87. Kongress der Deutschen Gesellschaft für Neurologie mit Fortbildungsakademie.Research output: SCORING: Contribution to book/anthology › Conference contribution - Poster › Research
- 2013
Comparability of 1.5T and 3.0T MRI-Volumetrics in Neurofibromatosis Type 1
Farschtschi, S. C., Dombi, E., Widemann, B., Fünsterer, C. & Mautner, V-F., 2013, Annual Meeting of the Children's Tumor Foundation.Research output: SCORING: Contribution to book/anthology › Conference contribution - Poster › Research
Response Of Spinal Ependymomas In Neurofibromatosis Type 2 to Bevacizumab - A Case Series
Farschtschi, S. C., David, W., Blakeley, J. O., Merker, V. L., Plotkin, S. R., Schuhmann, M. & Mautner, V-F., 2013, Annual Meeting of the Children's Tumor Foundation.Research output: SCORING: Contribution to book/anthology › Conference contribution - Poster › Research
- 2012
Charakteristische Mikroläsionen bei Schwannomatose?
Farschtschi, S. C., Bäumer, P., Pham, M., Bäumer, T. & Mautner, V-F., 09.2012, 85. Kongress der Deutschen Gesellschaft für Neurologie mit Fortbildungsakademie, CC Hamburg.Research output: SCORING: Contribution to book/anthology › Conference contribution - Poster › Research